In this regard, we have shown that endothelial dysfunction and endothelin-1 dysregulation are important and may represent potential therapeutic targets for patients with symptoms and/or signs of ischemia and no obstructive CAD (29). The gene discussed is EDN1; the disease is endothelial dysfunction.